AGM
AEMD icon

Alpine Global Management’s Aethlon Medical AEMD Stock Holding History

Alpine Global Management’s Portfolio AEMD Stock Details AEMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6
Closed -$34K – 207
2020
Q3 		$34K Buy
+6
New +$40.6K 0.01% 215

Other funds holding AEMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
CCP
Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return
CFN
Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Alpine Global Management's AEMD Position: Q4 2020 in Review

Alpine Global Management sold out of Aethlon Medical (AEMD) in Q4 2020, closing a stake of 6 shares — an estimated $34K sold.

Alpine Global Management first reported a position in AEMD in Q3 2020 and held it in 1 quarter. The position peaked at $34K in Q3 2020. 11 funds tracked by Wall St. Rank hold AEMD as of Q4 2020.

  • Alpine Global Management reported no remaining Aethlon Medical position as of Q4 2020 after selling out during the quarter.
  • Alpine Global Management sold 6 Aethlon Medical shares in Q4 2020, an estimated $34K.
  • Alpine Global Management first reported a position in Aethlon Medical in Q3 2020 and held it in 1 quarter.
  • Alpine Global Management's Aethlon Medical position peaked at $34K in Q3 2020.
  • 11 funds tracked by Wall St. Rank held Aethlon Medical as of Q4 2020.

Based on Alpine Global Management's 13F filing for Q4 2020, filed 12 Feb 2021.